Lenacapavir could be a game-changer for HIV prevention, but it is not being made available as PrEP
Last Updated:Together with 18 other HIV organisations, we’ve written to NHS England, NHS Wales, NICE and Gilead Sciences to call for action.
Latest news
Read the latest news from National AIDS Trust.
Our response to the new Welsh Programme for Government
Last Updated:Our response to Wales reaffirming its commitment to ending HIV by 2030.
Our response to Scotland developing a new HIV Action Plan
Last Updated:Our response to the news that Scotland is developing a new HIV Action Plan.
Our response to NICE’s decision not to recommend lenacapavir as PrEP
Last Updated:Our response to the National Institute for Health and Care Excellence (NICE) decision not to recommend lenacapavir as PrEP.
Our response to Grindr HIV data lawsuit
Last Updated:Our response to news that Grindr have paid £26m to settle UK lawsuit over allegedly sharing users' HIV status:
Life-saving HIV treatment now available on the NHS
Last Updated:A new life-saving HIV treatment is now available on NHS, following a sector campaign.
Our response to the latest A&E opt-out testing data
Last Updated:Our response to the news that 2,000 unidentified HIV cases have been found through A&E opt-out testing.
Our statement on the latest UKHSA data
Last Updated:Our response to the latest UKHSA report.
Statement on sentencing of Adam Hall for intentional transmission of HIV
Last Updated:National AIDS Trust, the UK’s HIV rights charity, responds to today’s sentencing of Adam Hall for rape and intentional transmission of HIV.